News about Drug Discovery & Development

Glenmark launches Type 2 diabetes drugs in India

The company has introduced 8 different combinations of sitagliptin-based drugs under the brand name SITAZIT<br />

Drug Discovery & Development | 07/07/2022 | By Sudeep Soparkar |  888

Aurigene Discovery Technologies inks partnership with EQRx

The parties would share both fundings for the discovery and development of the programmes

Drug Discovery & Development | 05/07/2022 | By Sudeep Soparkar |  1048

DFE Pharma expands its inhalation portfolio with the launch of Lactohale 400

Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
<br />

Drug Discovery & Development | 05/07/2022 | By Sudeep Soparkar |  946

Glenmark Pharma expand its OTC portfolio

Acquires approved ANDAs from Wockhardt

Drug Discovery & Development | 28/06/2022 | By Sudeep Soparkar |  725

Merck opens ?59 M CDMO facility to address critical cancer therapies

The 70,000 square foot facility, officially opened, brings 50 new jobs to the area

Drug Discovery & Development | 24/06/2022 | By Sudeep Soparkar |  710

Gericke ensures precise dosing operation with high-performance feeding unit

The right selection ensures recipe consistency and automated production to prevents product rejects

Drug Discovery & Development | 16/06/2022 | By Sudeep Soparkar |  405

I-Mab partners with MorphoSys

I-Mab partners with MorphoSys
Announces new license agreements for Felzartamab and TJ210

Drug Discovery & Development | 16/06/2022 | By Sudeep Soparkar |  853

Daiichi Sankyo's quizartinib plus chemotherapy improves OS in patients with AML

Quizartinib combined with standard induction and consolidation chemotherapy and then continued as a single agent demonstrated a 22.4 per cent reduction in the risk of death

Drug Discovery & Development | 13/06/2022 | By Sudeep Soparkar |  908

Autoimmune drug by Bristol Myers shows potential in lupus

Deucravacitinib is one of nine new drugs that Bristol Myers executives believe will help offset revenue losses

Drug Discovery & Development | 08/06/2022 | By Sudeep Soparkar |  852

PerkinElmer unveils ultrarapid whole-genome sequencing

The urWGS offering provides physicians with comprehensive, meaningful results in five days to help inform clinical management and improve outcomes

Drug Discovery & Development | 08/06/2022 | By Sudeep Soparkar |  559